LeonaBio (LONA) Other Accumulated Expenses (2019 - 2026)

LeonaBio (LONA) has 8 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q1 2026.

• Quarterly Other Accumulated Expenses fell 46.75% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 46.75% YoY) and the FY2025 annual result came in at $2.0 million, down 41.24% from the prior year.
• Other Accumulated Expenses declined to $1.3 million in Q1 2026 per LONA's latest filing, from $2.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $11.9 million in Q4 2023 and bottomed at $738000.0 in Q3 2025.
• The 5-year median for Other Accumulated Expenses is $5.1 million (2022), against an average of $5.7 million.
• The widest annual swing landed in 2023, when Other Accumulated Expenses soared 210.07%; it then tumbled 90.86% in 2025.
• Tracing LONA's Other Accumulated Expenses over 5 years: stood at $3.8 million in 2022, then soared by 210.07% to $11.9 million in 2023, then tumbled by 71.27% to $3.4 million in 2024, then plunged by 41.24% to $2.0 million in 2025, then plunged by 33.7% to $1.3 million in 2026.
• Per Business Quant, the three latest LONA Other Accumulated Expenses figures stand at $1.3 million (Q1 2026), $2.0 million (Q4 2025), and $738000.0 (Q3 2025).

Peer Comparison